COMPASS PATHWAYS PLC (CMPS) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Debt, CurrentUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $50.73M; Long-term DebtUSD $50.73M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Debt, CurrentUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $50.48M; Long-term DebtUSD $50.48M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $17.52M; Debt, CurrentUSD $17.52M; Long-term Debt, Excluding Current MaturitiesUSD $14.11M; Long-term DebtUSD $31.63M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
COMPASS PATHWAYS PLC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Debt, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Convertible Notes Payable, Current USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $50.73M | $50.73M | $1.43M | $0.00 | $21.67M | $25.98M | $6.23M | $0.00 | $50.00M | (m) | (m) |
| 2026-03-31 | $0.00 | $0.00 | $50.48M | $50.48M | $1.43M | $0.00 | $22.69M | $25.04M | $6.15M | $0.00 | $50.00M | (m) | (m) |
| 2025-12-31 | $17.52M | $17.52M | $14.11M | $31.63M | (m) | (m) | (m) | (m) | (m) | (m) | $30.00M | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | $18.25M | $13.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $12.67M | $12.67M | $18.60M | $31.27M | $18.25M | $13.17M | (m) | (m) | (m) | $0.00 | $30.00M | (m) | (m) |
| 2025-06-30 | $7.98M | $7.98M | $22.95M | $30.93M | $18.25M | $13.17M | (m) | (m) | (m) | $0.00 | $30.00M | (m) | (m) |
| 2025-03-31 | $8.99M | $8.99M | $21.55M | $30.54M | $14.17M | $10.67M | (m) | (m) | (m) | $6.59M | $30.00M | (m) | (m) |
| 2024-12-31 | $5.51M | $5.51M | $24.65M | $30.16M | (m) | (m) | (m) | (m) | (m) | (m) | $30.00M | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | $6.59M | $14.17M | $10.67M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.16M | $27.64M | $29.79M | $6.57M | $14.17M | $10.69M | (m) | (m) | $0.00 | $30.00M | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | $29.43M | $6.57M | $14.17M | $10.69M | (m) | (m) | $0.00 | $30.00M | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | $29.09M | $6.57M | $14.17M | $10.69M | (m) | (m) | $0.00 | $30.00M | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | $28.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $0.00 | (m) | $28.76M | (m) | (m) | (m) | (m) | (m) | (m) | $30.00M | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | $0.00 | $6.57M | $14.17M | $10.69M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | $28.43M | $0.00 | $6.57M | $14.17M | $10.69M | (m) | $0.00 | $30.00M | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | $28.12M | $0.00 | $6.59M | $14.17M | $10.67M | (m) | $0.00 | $30.00M | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $0.00 |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.40M | $8.69M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |